Focused on delivery
As the name behind some of the world’s most successful brands, we combine our knowledge, passion and entrepreneurial spirit to develop and supply innovative ingredients relied on by industries and consumers around the world. Our Purpose, Smart science to improve lives™, underpins our approach and guides what we do.
Our markets
Consumer Care
We develop innovative and sustainable ingredients that provide vital functionality to Consumer Care formulations, enabling customers to differentiate their products.
Already recognised as a market-leading innovator, our strategy is to continue to strengthen Consumer Care in fast growth niches, by accelerating innovation, expanding our sustainable product portfolio and enhancing our customer intimacy.
Life Sciences
We provide innovative delivery systems that enable the delivery of active ingredients in Pharma and Agriculture.
Our strategy is to expand Life Sciences to empower biologics delivery, enabling the move from small chemically synthesised molecules to large and complex biologics, a megatrend which is transforming the pharmaceutical market and will transform agriculture.
Reasons to invest in Croda
Strong fundamentals
A purpose-led business delivering positive impact
By developing and supplying ingredients that are included at low inclusion levels but are vital to the functionality and claims of our customers’ products, we can have an outsized positive impact, applying our Smart science to improve lives™.
We partner and create value across the full development lifecycle
Direct selling supports customer intimacy, with customer insight informing innovation priorities. We partner with customers, academia and SMEs to develop ingredients that address global challenges and build strong relationships in the process.
Our high-performance and innovation focused culture is unique
As a people-based business our culture is pivotal to our success and our unique values-based culture transcends our global operations.
A proven strategic direction
At the forefront to capture growth opportunities presented by megatrends
Long-term technology trends such as the demand for sustainable ingredients and the move to biologics are presenting significant opportunities for growth. We have aligned our portfolio with these megatrends, enabling us to help address some of the world’s biggest challenges.
A strategy built on sustainability and innovation
Our strategy builds on our heritage of producing innovative ingredients from natural raw materials, combining sustainability and innovation to deliver growth.
Focused on operational delivery
We are optimising performance in a challenging environment while simplifying our structure, processes and ways of working to support future growth. By continually improving customer service and efficiency, and focusing on operational delivery we will leverage the power of our strong foundations.
Driving efficiency across the Group
We are controlling what we can control, optimising performance in a challenging market environment through short-term cost measures and site optimisation. These are alongside longer-term operational improvements such as our ‘doing the basics brilliantly’ programme, which is improving our processes and ways of working, benefitting the customer experience.
An organisational structure that leverages our strengths
Our new organisational structure, introduced in January 2024, aligns the accountability for strategy and performance, creating greater ownership and improving agility and customer responsiveness.
Continuing to invest in future growth
Despite short-term pressures we continue to invest in future growth, matching our customers’ appetite for innovation through targeted investment in R&D and manufacturing, with continued capital discipline.
Delivering long-term performance
Our strong track record of growth over many decades and high cash conversion have enabled us to grow the dividend for more than 30 years. With our growth strategy supported by structural trends and conservative leverage, we are well positioned to deliver continued out-performance.
A long-term track record
Our successful business model has enabled us to pay a growing dividend for more than 30 years. Increasing shareholder returns have been delivered alongside strong non-financial performance.
Consistent capital allocation in line with a clear policy
A clear capital allocation policy guides our investment decisions with a preference for organic capital investment, complemented by technology-led ‘bolt-on’ acquisitions, which has delivered attractive long-term growth.
Retained a strong financial position despite market headwinds
Despite market headwinds and a weaker performance in 2023, our cash generative business model and disciplined approach mean we have retained a strong balance sheet and the headroom to invest.